ARWR
Arrowhead Pharmaceuticals
$85.53
−$0.07 (−0.08%)Jul 27, 2026
Key metrics
The numbers that frame ARWR today
- Market cap
- $12.05B
- P/E (TTM)
- -40.0
- EV / FCF
- -260.1
- Gross margin
- 100%
- EV / Sales
- 21.3
- ROIC
- -9.1%
- Div yield
- 0%
- Debt / equity
- 2.2
- 52wk Low
- $15.01
- 52wk High
- $95.49
Growth
Revenue and earnings trend for ARWR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ARWR
Is Arrowhead Pharmaceuticals a good buy?
Hold. Arrowhead Pharmaceuticals has mixed quality and excellent momentum. The setup is mixed. Growth looks poor. That could put pressure on the long-term business case. We think Arrowhead Pharmaceuticals is selling at a high price.
What is the market capitalization of ARWR?
Arrowhead Pharmaceuticals's market capitalization is $12.05B.
What is the P/E ratio for ARWR stock?
Arrowhead Pharmaceuticals's current P/E ratio is -40.
What is the 52-week high for ARWR stock?
The 52-week high for Arrowhead Pharmaceuticals is $95.49. The current close of $85.53 is 10.4% below that high.
What is the 52-week low for ARWR stock?
The 52-week low for Arrowhead Pharmaceuticals is $15.01. The current close of $85.53 is 469.8% above that low.
Does ARWR stock pay dividends?
Arrowhead Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ARWR?
Arrowhead Pharmaceuticals's Debt / Equity ratio is 2.24.